Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.40
-0.30 (-0.76%)
At close: May 8, 2026

Maxigen Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,5333,8384,3654,3044,0363,996
Market Cap Growth
0.00%-12.06%1.40%6.65%0.99%151.22%
Enterprise Value
2,6823,1073,8213,8843,3243,534
Last Close Price
39.4042.8048.0346.4743.2042.77
PE Ratio
13.0414.4722.9525.9628.9545.59
Forward PE
-10.5310.5310.5310.5310.53
PS Ratio
4.284.736.416.926.687.81
PB Ratio
2.172.503.173.163.123.50
P/TBV Ratio
2.172.503.173.163.123.51
P/FCF Ratio
16.7618.4216.3828.9415.8938.67
P/OCF Ratio
11.9813.2314.6425.1415.0433.98
EV/Sales Ratio
3.253.835.616.245.506.90
EV/EBITDA Ratio
8.8910.6018.4821.9421.2129.51
EV/EBIT Ratio
10.0311.9021.2425.9225.8439.28
EV/FCF Ratio
12.7214.9114.3426.1113.0834.20
Debt / Equity Ratio
0.060.07---0.01
Debt / EBITDA Ratio
0.330.34---0.08
Debt / FCF Ratio
0.470.48---0.09
Net Debt / Equity Ratio
-0.52-0.50-0.46-0.32-0.62-0.45
Net Debt / EBITDA Ratio
-2.82-2.65-3.09-2.43-5.10-4.32
Net Debt / FCF Ratio
-4.04-3.72-2.40-2.90-3.15-5.01
Asset Turnover
0.450.470.440.420.450.46
Inventory Turnover
3.052.832.452.462.952.98
Quick Ratio
3.022.893.614.025.945.53
Current Ratio
3.323.214.034.726.566.75
Return on Equity (ROE)
17.46%18.22%13.90%12.48%11.44%8.76%
Return on Assets (ROA)
9.07%9.39%7.31%6.37%5.93%5.06%
Return on Invested Capital (ROIC)
30.06%28.44%18.21%18.05%19.31%12.57%
Return on Capital Employed (ROCE)
16.40%16.90%13.10%11.00%9.90%7.80%
Earnings Yield
7.67%6.91%4.36%3.85%3.45%2.19%
FCF Yield
5.97%5.43%6.11%3.46%6.30%2.59%
Dividend Yield
2.11%-1.73%2.15%1.10%-
Payout Ratio
27.46%28.05%46.78%25.54%-64.18%
Buyback Yield / Dilution
0.47%-0.77%-0.27%-0.07%-5.78%-4.81%
Total Shareholder Return
2.58%-0.77%1.46%2.08%-4.68%-4.81%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.